In the unadjusted analysis of categorical outcomes, younger women taking prescription opioids had higher odds of class II and class III obesity and metabolic syndrome, high waist circumference, high triglycerides, low serum iron, high serum transferrin receptor, and low percent serum transferrin saturation (Supplemental Table S2). Here, TF is linked to metabolic syndrome.